Scientia Professor Vlado Perkovic

Scientia Professor Vlado Perkovic is the Dean of Medicine and Health at the University of New South Wales in Sydney, Australia, an active clinician and a leading clinical trialist. Prior to commencing his current role in 2019, Professor Perkovic was Executive Director of The George Institute, Australia. He is a part time (0.1 FTE) Staff […]

Scientia Professor Vlado Perkovic is the Dean of Medicine and Health at the University of New South Wales in Sydney, Australia, an active clinician and a leading clinical trialist. Prior to commencing his current role in 2019, Professor Perkovic was Executive Director of The George Institute, Australia. He is a part time (0.1 FTE) Staff Specialist in Nephrology at the Royal North Shore Hospital. His research focus is on clinical trials and epidemiology, in particular in preventing the progression of kidney disease and its complications. He has served on the Steering Committees of a large number of international clinical trials including some that have completed- CREDENCE (Chair), TESTING (Chair), CARMELINA (Co-Chair), SONAR and CANVAS- and several that are ongoing- FLOW (Chair), ZEUS (Co-Chair), ASPIRED (Co-Chair), RESOLVE, and TRACK.

He has played a central role in the development of an affordable dialysis system, which was a Eureka Prize finalist in 2017 and won first prize in the World Innovation Summit for Health 2020 Innovation Booster competition.

He has previously been a member of the National Health and Medical Research Council Principal Committee on Research Translation, the Board of the Australian Clinical Trials Alliance. was President of the Association of Australian Medical Research Institutes (AAMRI), and was Chair of the International Society of Nephrology Advancing Clinical Trials (ISN-ACT) group.

He is a Fellow of the Australian Academy of Health and Medical Sciences, has been classified as a Highly Cited Researcher by Clarivate (among the top 0.1% of most cited authors worldwide in 2019 and 2020) and serves on the Editorial Boards of a number of leading specialist and general journals, including the Journal of the American Society of Nephrology, Circulation, and the New England Journal of Medicine.

Share this post

No comments


Leave a Comment